Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Tarčno zdravljenje slovenskih bolnikov z razsejanimi gastrointestinalnimi stromalnimi tumorji
Authors:ID Unk, Mojca (Author)
ID Matos, Erika (Author)
ID Eržen, Darja (Author)
ID Zakotnik, Branko (Author)
Files:.pdf PDF - Presentation file, download (332,26 KB)
MD5: 62FE713B3207852B073E02270FD640CF
PID: 20.500.12556/dirros/5fd3135f-bd63-4eb9-9130-48359e2d3c98
 
Language:Slovenian
Typology:1.02 - Review Article
Organization:Logo OI - Institute of Oncology
Abstract:Klasifikacija, diagnostika in zdravljenje stromalnih ter mezenhimskih neoplazem prebavil je v zadnjih 30 letih doživela obsežen napredek. Gastrointestinalni stromalni tumorji (GIST) predstavljajo manj kot 1 % vseh malignih tumorjev prebavil.Klinična slika je odvisna od mesta, velikosti in malignega potenciala GIST. Razsejani GIST predstavlja primer uspešnega zdravljenja s tarčno terapijo, saj se je z odkritjem KIT in PDGFR signalne poti ter tirozin kinaznih inhibitorjev, kot staimatinib mesilat in sunitinib, prognoza te bolezni pomembno izboljšala. Izhod zdravljenja slovenskih bolnikov z razsejanim GIST je primerljiv z izhodom zdravljenja bolnikov, ki so bili zdravljeni v pomembnih večjih mednarodnih kliničnih raziskavah, srednji čas do progresa bolezni pri naših bolnikih je 52 mesecev in srednje preživetje 72 mesecev. Uporabljali smo protokol sledenja, ki je poleg kontrastne računalniške tomografije trebuha vključeval tudi preiskavo trebuha z ultrazvokom. S tem smo ob primerljivem preživetju izboljšali kakovost življenja naših bolnikov in zmanjšali stroške zdravljenja.
Keywords:razsejani tumorji, tarčno zdravljenje, rak prebavil, gastrointestinalni stromalni tumorji
Publication status:Published
Publication version:Version of Record
Year of publishing:2013
Number of pages:str. 84-86, 153
Numbering:Letn. 17, št. 2
PID:20.500.12556/DiRROS-9126 New window
UDC:616.3-006-08
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-JL6W1JHX
COBISS.SI-ID:1679739 New window
Copyright:by Authors
Publication date in DiRROS:31.08.2018
Views:3088
Downloads:815
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija. strokovni časopis za zdravnike
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:English
Title:Target treatment of Slovenian patients with metastatic gastrointestinal stromal tumours
Abstract:In the last 30 years, major progress has been made in the classification, diagnosis and treatment of gastrointestinal stromal and mesenchymal neoplasms. Gastrointestinal stromal tumours (GIST) represent less than 1% of all malignant gastrointestinal tumours. The clinical picture depends on the site, size and malignant potential of the GIST. Metastatic GIST is a case of successful treatment, as the detection of KIT- and PDGFR-signalling pathways and kinase inhibitors, such as imatinib, mesylate and sunitinib, has significantly improved the prognosis of this disease. The treatment outcome in Slovenian patients with metastatic GIST is comparable to the treatment outcome observed in patients treated in major international clinical trials. We used the follow-up protocol which, besides contrast computed tomography of the abdomen, also included ultrasound of the abdomen. By doing so, along with comparable survival rates, we improved the quality of life of our patients and reduced the treatment costs.


Archive

niGradiv

Back